Latest News about NVS
Recent news which mentions NVS
From Benzinga
 
   Emergent BioSolutions Soars: Analyst Upgrades Stock With Near 100% Upside After FDA's Positive Move
   
  
  
  April 10, 2023
  From Benzinga
 From Benzinga
 
   6 Questions With Rocket Pharma's CEO On World Health Day: How The Biotech Is 'Changing The Narrative'
   
  
  
  April 07, 2023
  From Benzinga
 
   7 Very Undervalued Penny Stocks to Buy in April 2023
   
  
  
  April 06, 2023
  From InvestorPlace
 From Motley Fool
 
   Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
   
  
  
  March 27, 2023
  From Benzinga
 From Benzinga
 From Benzinga
 
   Why Novartis Shares Are Trading Higher Premarket Today
   
  
  
  March 27, 2023
  From Benzinga
 
   First Citizens shares leap on SVB deal as Novartis stock boosted by breast-cancer drug trial
   
  
  
  March 27, 2023
  From MarketWatch
 
   First Republic Bank, KeyCorp And Other Big Stocks Moving Higher In Monday's Pre-Market Session
   
  
  
  March 27, 2023
  From Benzinga
 
   2 Biotech Stocks That Could Make You Richer
   
  
  
  March 21, 2023
  From Motley Fool
 From Benzinga
 
   Novartis Reveals Long-Term Data Of Atrophy Gene Therapy Exhibiting Sustained Durability Of Up To 7.5 Years
   
  March 20, 2023
  Tickers 
   NVS
  
  
  From Benzinga
 
   FDA Approves Novartis' Tafinlar + Mekinist For Pediatric Brain Cancer With Certain Mutations
   
  March 17, 2023
  Tickers 
   NVS
  
  
  From Benzinga
 From Benzinga
 
   Novartis' Prostate Cancer Therapy Hit By Supply Crunch, Seeks To Ramp Up Production To Ease Supply Issues
   
  March 16, 2023
  Tickers 
   NVS
  
  
  From Benzinga
 From InvestorPlace
 From Benzinga
 
   4 AI Stocks That Are Revolutionizing Healthcare
   
  
  
  March 06, 2023
  From InvestorPlace
 
   This Company Is Focused on Treg-Enhancing Therapies - Could This Be Medicine's Next Frontier?
   
  
  
  March 03, 2023
  From Benzinga
 From MarketWatch
 
   Novartis Takes Down $80M NASH Pact With Pliant Therapeutics
   
  
  
  February 24, 2023
  From Benzinga
 
   Better Buy: Beam Therapeutics or Intellia Therapeutics?
   
  
  
  February 22, 2023
  From Motley Fool
 
   This chart gives one reason European stocks may continue to outperform U.S. equities
   
  
  
  February 17, 2023
  From MarketWatch
 
   Cantor On MoonLake Immunotherapeutics - Initiates On Inexpensive Valuation, Strong Catalyst Path
   
  
  
  February 14, 2023
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.